myeloprolferative disorders Flashcards
technically four type of Myeloprolfierative diseases
CML - excess neutrophils
Polycythemia vera (PV): excess RBCs
idiopathic myelofibrosis (MF): excess megakaryocytes
essential thrombocythemia (ET): excess platelets
underlying pathology of myeloprolfierative disorders
Excess proliferation of fully differentiated cells - from the myeloid line
ET?
essential thrombocytopenia (excess platelets)
Bloods and blood film for ET?
raised platelet count
blood film: lots of platelets, differentiate sizes
PC for ET?
arterial, venous thromboses, digital ischaemia, gout, splenomegaly
Gene mutation association with ET
JAK2 (50%)
polycythemia vera (PV)?
excess RBCs
RBC maturation without EPO
PC of PV
red face headaches itch arterial thrombosis: CLI (ALI) tia, stroke splenomegaly
Gene mutation association with PV
JAK2 (95%)
Bloods for PV
- +++Hc, ++ RBC, high HB (Until iron stores run out… then decreases)
MEASURE EPO LEVEL - differentials
o +++ WBC, +++ platelet count.
o +++ uric acid: high turnover – gout
o Low MCV
Due to iron deficiency, due to excessive production
EPO level in PV
excess RBCs production leads to suppression of EPO production - so LOW
pathology of idiopathic myelofibrosis (MF)
JAK2 mutation
due to excess megakaryocytes,
leads to scarring of the bone marrow
PC of idiopathic myelofibrosis
older
tx for myeloprolfierative disorders
aspirin
hydroxycarbamide
JAK2 inhibitor: Ruxolitinib
specific tx for PV
venesection in order to reduce haemoatocrit
low iron but do not give iron - will exacerbate situation